Collplant Biotechnologies

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$179
$2,055
$164
$4
Gross Profit
-236
1,867
-108
-268
EBITDA
-2,949
-1,404
-3,732
-4,287
EBIT
-3,178
-1,648
-3,974
-4,542
Net Income
-3,347
-1,452
-3,878
-4,326
Net Change In Cash
179
2,055
164
4
Free Cash Flow
-2,460
-1,176
-3,523
-3,588
Cash
11,707
10,735
11,909
15,371
Basic Shares
11,840
11,454
11,454
11,454

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$515
$10,959
$299
$15,641
Gross Profit
-1,110
8,968
-101
13,636
EBITDA
-16,213
-6,410
-16,021
838
EBIT
-17,251
-7,512
-17,097
65
Net Income
-16,609
-7,019
-16,753
409
Net Change In Cash
515
10,959
299
15,641
Free Cash Flow
-14,576
-3,717
-15,014
912
Cash
11,909
26,674
29,653
13,148
Basic Shares
11,454
11,389
11,033
11,966

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.23
2025-03-31
-$0.13
2024-12-31
-$0.33